TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down May 31, 2013
TCL Archive NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive March 23, 1984
TCL Archive Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts February 15, 1985
TCL Archive Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions November 6, 1981
